Evercore ISI Issues Positive Forecast for Envista (NYSE:NVST) Stock Price

Envista (NYSE:NVST - Get Free Report) had its target price hoisted by stock analysts at Evercore ISI from $19.00 to $23.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage currently has an "outperform" rating on the stock. Evercore ISI's price target indicates a potential upside of 13.92% from the company's current price.

Several other brokerages have also weighed in on NVST. UBS Group decreased their price objective on Envista from $21.00 to $18.00 and set a "neutral" rating on the stock in a report on Monday, May 5th. Baird R W raised shares of Envista from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, May 27th. Morgan Stanley set a $16.00 price target on shares of Envista in a research note on Tuesday, April 15th. Bank of America dropped their target price on Envista from $26.00 to $23.00 and set a "buy" rating for the company in a report on Tuesday, April 29th. Finally, Piper Sandler decreased their price target on Envista from $18.00 to $17.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 30th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Envista currently has an average rating of "Hold" and an average target price of $20.23.

Envista Stock Performance

NVST stock traded down $0.53 on Wednesday, reaching $20.19. 1,852,889 shares of the company were exchanged, compared to its average volume of 2,487,417. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.12 and a quick ratio of 1.82. Envista has a 12 month low of $14.22 and a 12 month high of $23.00. The stock's fifty day moving average price is $18.58 and its 200 day moving average price is $18.51. The firm has a market capitalization of $3.42 billion, a PE ratio of -3.09, a PEG ratio of 1.30 and a beta of 1.00.

Envista (NYSE:NVST - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The company reported $0.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.20 by $0.04. Envista had a negative net margin of 44.90% and a positive return on equity of 4.07%. The company had revenue of $616.90 million for the quarter, compared to the consensus estimate of $608.17 million. During the same quarter in the previous year, the firm posted $0.26 EPS. The business's revenue was down 1.1% compared to the same quarter last year. On average, research analysts anticipate that Envista will post 1 EPS for the current fiscal year.

Institutional Investors Weigh In On Envista

A number of institutional investors and hedge funds have recently made changes to their positions in the company. GAMMA Investing LLC increased its position in Envista by 1,338.3% in the first quarter. GAMMA Investing LLC now owns 33,139 shares of the company's stock worth $572,000 after purchasing an additional 30,835 shares during the period. Two Sigma Advisers LP raised its stake in shares of Envista by 66.6% during the fourth quarter. Two Sigma Advisers LP now owns 47,800 shares of the company's stock worth $922,000 after buying an additional 19,100 shares during the last quarter. Comerica Bank lifted its holdings in Envista by 8.2% in the fourth quarter. Comerica Bank now owns 121,851 shares of the company's stock valued at $2,350,000 after buying an additional 9,248 shares during the period. Wealth Enhancement Advisory Services LLC increased its stake in shares of Envista by 220.5% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 47,319 shares of the company's stock valued at $817,000 after acquiring an additional 32,556 shares during the last quarter. Finally, Norges Bank acquired a new position in Envista in the fourth quarter valued at about $38,052,000.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.